"Fibrinolytic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
| Descriptor ID |
D005343
|
| MeSH Number(s) |
D27.505.519.421.750 D27.505.954.411.320 D27.505.954.502.427
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrinolytic Agents".
Below are MeSH descriptors whose meaning is more specific than "Fibrinolytic Agents".
This graph shows the total number of publications written about "Fibrinolytic Agents" by people in this website by year, and whether "Fibrinolytic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 |
| 1994 | 2 | 2 | 4 |
| 1997 | 2 | 0 | 2 |
| 1999 | 7 | 1 | 8 |
| 2000 | 4 | 1 | 5 |
| 2001 | 6 | 0 | 6 |
| 2002 | 4 | 1 | 5 |
| 2003 | 5 | 7 | 12 |
| 2004 | 11 | 2 | 13 |
| 2005 | 7 | 4 | 11 |
| 2006 | 7 | 5 | 12 |
| 2007 | 1 | 8 | 9 |
| 2008 | 11 | 3 | 14 |
| 2009 | 9 | 3 | 12 |
| 2010 | 6 | 5 | 11 |
| 2011 | 0 | 5 | 5 |
| 2012 | 6 | 7 | 13 |
| 2013 | 7 | 5 | 12 |
| 2014 | 15 | 5 | 20 |
| 2015 | 10 | 5 | 15 |
| 2016 | 6 | 1 | 7 |
| 2017 | 6 | 2 | 8 |
| 2018 | 13 | 5 | 18 |
| 2019 | 7 | 6 | 13 |
| 2020 | 2 | 4 | 6 |
| 2021 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibrinolytic Agents" by people in Profiles.
-
Rodriguez F, Harrington RA. Antithrombotic Therapy after Acute Coronary Syndromes. Reply. N Engl J Med. 2021 05 13; 384(19):1873-1874.
-
Al Kasab S, Almallouhi E, Grant C, Hewitt D, Hewitt J, Baki M, Sabatino P, Jones D, Holmstedt CA. Telestroke Consultation in the Emergency Medical Services Unit: A Novel Approach to Improve Thrombolysis Times. J Stroke Cerebrovasc Dis. 2021 May; 30(5):105710.
-
Rodriguez F, Harrington RA. Management of Antithrombotic Therapy after Acute Coronary Syndromes. N Engl J Med. 2021 Feb 04; 384(5):452-460.
-
Moraney R, Poupore N, Shugart R, Tate M, Snell A, Brown K, Nathaniel TI. Thrombolytic therapy in ischemic stroke patients with pre-stroke depression in the telestroke vs non-telestroke. J Stroke Cerebrovasc Dis. 2020 Sep; 29(9):104890.
-
Harrigan MR, Griffin RL, Deveikis JP, Prattipati V, Chimowitz MI, Jansen JO. New ischemic lesions on brain magnetic resonance imaging in patients with blunt traumatic cerebrovascular injury. J Trauma Acute Care Surg. 2020 06; 88(6):796-802.
-
Almallouhi E, Ajinkya S, Rahwan M, Holmstedt CA, Al Kasab S. Impact of Stroke Center Certification on Thrombolysis Time Metrics in Telestroke Setting. Telemed J E Health. 2021 02; 27(2):167-171.
-
Poupore N, Strat D, Mackey T, Brown K, Snell A, Nathaniel TI. Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients. Lipids Health Dis. 2020 May 06; 19(1):84.
-
Simpson AN, Harvey JB, DiLembo SM, Debenham E, Holmstedt CA, Robinson CO, Simpson KN, Almallouhi E, Ford DW. Population Health Indicators Associated with a Statewide Telestroke Program. Telemed J E Health. 2020 09; 26(9):1126-1133.
-
Rotimi OR, Ajani IF, Penwell A, Lari S, Walker B, Nathaniel TI. In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy? Womens Health (Lond). 2020 Jan-Dec; 16:1745506520922760.
-
Ajinkya S, Almallouhi E, Turner N, Al Kasab S, Holmstedt CA. Racial/Ethnic Disparities in Acute Ischemic Stroke Treatment Within a Telestroke Network. Telemed J E Health. 2020 10; 26(10):1221-1225.